Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | CNR2 | P34972 | 4/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | CCR5 | P51681 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10047068 | 0.79 | CNR2 (0.44) | HTTCNR2CNR1ACHES1PR1 | |
| SCHEMBL528739 | 0.75 | LMNA (0.44) | HTTCNR2CNR1ACHES1PR1 | |
| SCHEMBL13676231 | 0.74 | BCHE (0.53) | CNR2KDM4EALDH1A1 | |
| SCHEMBL11465948 | 0.73 | CNR2 (0.41) | HTTCNR2CNR1ACHES1PR1 | |
| SCHEMBL1300316 | 0.73 | CNR2 (0.42) | CNR2MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL19380754 | 0.72 | BCHE (0.54) | CNR2MEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL7141111 | 0.72 | HTT (0.63) | HTTCNR2CNR1ACHEMEN1 | |
| SCHEMBL11508330 | 0.72 | CNR2 (0.38) | HTTCNR2CNR1S1PR1MEN1 | |
| SCHEMBL21322829 | 0.72 | CNR2 (0.47) | CNR2CNR1KDM4EALDH1A1 | |
| SCHEMBL20367672 | 0.71 | CNR2 (0.37) | HTTCNR2CNR1ACHES1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109071458-B | Triamide compounds and compositions comprising the same | 美利肯公司 | 2021-12-10 | — | — | CN | disclosed |
| EP-3426639-B1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | MILLIKEN & CO (US) | 2021-05-05 | — | — | EP | disclosed |
| US-10844006-B2 | Trisamide compounds and compositions comprising the same | MILLIKEN & COMPANY (US) | 2020-11-24 | — | — | US | disclosed |
| CN-109071458-A | Triamide and composition comprising the triamide | 美利肯公司 | 2018-12-21 | — | — | CN | disclosed |
| US-20170260129-A1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | MILLIKEN & CO (US) | 2017-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10844006-B2 | Trisamide compounds and compositions comprising the same | TELO2, TERT, H1-2 | HTT 205/4885CNR2 465/4885CNR1 567/4885 |
| US-20170260129-A1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | TELO2, TERT, H1-2 | HTT 205/4885CNR2 465/4885CNR1 567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.